Clinical Data, Inc. to Host Investor Day and Webcast October 8, 2009

Mon. October 05, 2009; Posted: 10:00 AM

NEWTON, Mass., Oct 05, 2009 (BUSINESS WIRE) -- CLDA | Quote | Chart | News | PowerRating -- Clinical Data, Inc. (NASDAQ: CLDA), today announced that it will host an Investor Day on Thursday, October 8, 2009 beginning at 8:30 a.m. EDT in New York City. The program, "Focus on Vilazodone: A Potential New Treatment for Depression," will feature a series of presentations and panel discussion by leading experts in the treatment of depression, antidepressants and related sexual dysfunction.

Investment professionals interested in attending Clinical Data's investor event should contact Amanda Brown at abrown@clda.com or (617) 527-9933 x3345.

Date:                 Thursday, October 8, 2009
Time:                 8:30 a.m. Presentations commence.
Webcast:              Available through the Company's website: www.clda.com.
                      Please click on the "Investor Relations" link on the homepage to
                      access events at least five minutes prior to the start of the
                      webcast.
Dial-In Information:
                      888-245-0960 or 913-312-1467 (international)
                      Passcode 7458158

The presentation will be available via webcast and telephonic archive for 30 days beginning two hours after the completion of the live event.

About Clinical Data, Inc.

Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for central nervous system disorders and cardiovascular diseases, to be followed by promising drug candidates in major therapeutic areas including oncology and inflammatory diseases. Clinical Data plans to differentiate its therapeutics by combining its drug development and biomarker expertise to develop products with enhanced efficacy and tolerability, improving patient health and reducing costs. To learn more, please visit the Company's website at www.clda.com.

SOURCE: Clinical Data, Inc.

Clinical Data, Inc. 
Theresa McNeely, 617-527-9933 x3373 
Vice President 
Corporate Communications

For full details on Clinical Data Inc (CLDA) click here. Clinical Data Inc (CLDA) has Short Term PowerRatings of 10. Details on Clinical Data Inc (CLDA) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.